title: Managing metastatic prostate cancer.
abstract: Prostate cancer is one of the most commonly diagnosed malignancies in the west. Most patients with metastatic or recurrent prostate cancer initially respond to androgen deprivation therapy, but almost all eventually progress. This review will focus on current treatment options for metastatic prostate cancer, with a focus on hormonal therapies, chemotherapy and treatment of bony disease, along with biological and targeted therapy.
authors.affiliation: Imperial College, Hammersmith Campus, London W12 0NN.
authors.forename: S
authors.initials: S
authors.lastname: Ngan
authors.forename: D
authors.initials: D
authors.lastname: Mazhar
authors.forename: J
authors.initials: J
authors.lastname: Waxman
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000628:therapy*; D011868:Radioisotopes / Q000627:therapeutic use
chemical_list: D000726:Androgen Antagonists; D000970:Antineoplastic Agents; D011868:Radioisotopes